Answers are grounded in this paper and cite their sources.
Case series reports complete remission in 60% of pediatric PMF patients treated with phototherapy, suggesting a positive prognosis.
Papular mycosis fungoides (PMF) is a rare clinical variant with limited data on long‐term outcomes, particularly in children. Our study describes sociodemographic, clinical, therapeutic, and follow‐up data in 5 pediatric patients with PMF, all treated with phototherapy (PUVA, PUVAsol or narrowband UVB). Complete remission was achieved by 60% within a median of 6 months (IQR 4.5–7.5 months), and the median follow‐up was 19 months (IQR 6–27 months), with no disease progression and 100% overall survival. These findings suggest that papular MF follows a favorable course, similar to early‐stage MF or other clinical variants with a positive prognosis.
No takes yet. Share an insight, caveat, or question.
Vega et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: